Diclofenac thrombocytopenia with

Kramer, M.R., Levene, C., and Hershko, C., Severe reversible autoimmune haemolytic anaemia and thrombocytopenia associated with diclofenac therapy. Scand. J. Haematol., 36, 118, 1986. 

Among the more severe adverse reactions, Stevens-Johnson epidermal necrolysis syndrome, thrombocytopenia, agranulocytosis, and nephrotic syndrome have all been observed. Like diclofenac, sulindac may have some propensity to cause elevation of serum aminotransferases it is also sometimes associated with cholestatic liver damage, which disappears when the drug is stopped. 

Diclofenac can cause panmyelopathy (8). Data from the International Agranulocytosis and Aplastic Anemia Study showed an increased risk of aplastic anemia (multivariate rate-ratio 8.8) (9). Fatal aplastic anemia has also been described (SEDA-4, 69) (10), as have purpura and thrombocytopenia, although not always with certainty. Spontaneous bleeding (subcutaneous bruises, hematoma, greater wound drainage) has been associated with diclofenac (SEDA-15,100). 

---